FRESENIUS MEDICAL CARE AG Effect Of Exchange Rate Changes On Cash And Cash Equivalents
FRESENIUS MEDICAL CARE AG (FMS) reported Effect Of Exchange Rate Changes On Cash And Cash Equivalents of -EUR 141.48 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Cash Flow
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG effect of exchange rate changes on cash and cash equivalents for the quarter ending 2025-03-31 was -22.43M EUR.
- FRESENIUS MEDICAL CARE AG effect of exchange rate changes on cash and cash equivalents for the quarter ending 2024-03-31 was -4.51M EUR.
- FRESENIUS MEDICAL CARE AG effect of exchange rate changes on cash and cash equivalents for the quarter ending 2023-03-31 was -31.47M EUR, a 387.47% decline year-over-year.
- FRESENIUS MEDICAL CARE AG effect of exchange rate changes on cash and cash equivalents for the quarter ending 2022-03-31 was 10.95M EUR, a 75.27% decline year-over-year.
| Period end | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 3 month | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 6 month | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 9 month | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 12 month |
|---|---|---|---|---|
| 2025-12-31 | -141.48M EUR 20-F · filed 2026-02-24 | |||
| 2025-09-30 | -109.30M EUR 6-K · filed 2025-11-04 | |||
| 2025-06-30 | -93.08M EUR 6-K · filed 2025-08-05 | |||
| 2025-03-31 | -22.43M EUR 6-K · filed 2025-05-06 | |||
| 2024-12-31 | 26.20M EUR 20-F · filed 2026-02-24 | |||
| 2024-09-30 | -24.59M EUR 6-K · filed 2025-11-04 | |||
| 2024-06-30 | -12.23M EUR 6-K · filed 2025-08-05 | |||
| 2024-03-31 | -4.51M EUR 6-K · filed 2025-05-06 | |||
| 2023-12-31 | -72.61M EUR 20-F · filed 2026-02-24 | |||
| 2023-09-30 | -48.56M EUR 6-K · filed 2024-11-05 | |||
| 2023-06-30 | -65.30M EUR 6-K · filed 2024-07-30 | |||
| 2023-03-31 | -31.47M EUR 6-K · filed 2024-05-07 | |||
| 2022-12-31 | -23.16M EUR 20-F · filed 2025-02-25 | |||
| 2022-09-30 | 71.40M EUR 6-K · filed 2023-11-02 | |||
| 2022-06-30 | 36.81M EUR 6-K · filed 2023-08-02 | |||
| 2022-03-31 | 10.95M EUR 6-K · filed 2023-05-09 | |||
| 2021-12-31 | 131.23M EUR 20-F · filed 2024-02-20 | |||
| 2021-09-30 | 100.13M EUR 6-K · filed 2022-10-31 | |||
| 2021-06-30 | 49.15M EUR 6-K · filed 2022-08-02 | |||
| 2021-03-31 | 44.26M EUR 6-K · filed 2022-05-04 | |||
| 2020-12-31 | -160.37M EUR 20-F · filed 2023-02-22 | |||
| 2020-09-30 | -82.00M EUR 6-K · filed 2021-11-02 | |||
| 2020-06-30 | -26.38M EUR 6-K · filed 2021-07-30 | |||
| 2020-03-31 | 4.28M EUR 6-K · filed 2021-05-06 | |||
| 2019-12-31 | 47.76M EUR 20-F · filed 2022-02-22 | |||
| 2019-09-30 | 70.67M EUR 6-K · filed 2020-10-29 | |||
| 2019-06-30 | 18.39M EUR 6-K · filed 2020-07-30 | |||
| 2019-03-31 | 31.89M EUR 6-K · filed 2020-05-06 | |||
| 2018-12-31 | 32.39M EUR 20-F · filed 2021-02-23 | |||
| 2018-09-30 | -10.68M EUR 6-K · filed 2019-10-31 | |||
| 2018-06-30 | -17.60M EUR 6-K · filed 2019-07-30 | |||
| 2018-03-31 | -25.13M EUR 6-K · filed 2019-05-02 | |||
| 2017-12-31 | -132.41M EUR 20-F · filed 2020-02-20 | |||
| 2017-09-30 | -77.30M EUR 6-K · filed 2018-10-30 | |||
| 2017-06-30 | -68.44M EUR 6-K · filed 2018-08-01 | |||
| 2017-03-31 | 692.00K EUR 6-K · filed 2018-05-03 | |||
| 2016-12-31 | 38.01M EUR 20-F · filed 2019-02-20 | |||
| 2015-12-31 | 25.42M EUR 20-F · filed 2018-02-27 |